Stason Pharmaceuticals Inc dba Imt Stason Laboratories
- View government funding actions
- Irvine, CA 926182005
- Phone: 949-380-4327
- Corporate URL: www.microspheres.net
- Estimated Number of Employees: 50
- Estimated Annual Receipts: $5,000,000
- Business Start Date: 1989
- Contact Person: Krista Chang
- Contact Phone: 949-380-4327
- Contact Email: krista.chang@stasonpharma.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- Minority Owned Business
- For Profit Organization
- Asian-Pacific American Owned
- Industries Served: Medicinal and Botanical Manufacturing, Pharmaceutical Preparation Manufacturing, Testing Laboratories, Research and Development in Biotechnology, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology), Medical Laboratories
- Product Areas: R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), BIOMEDICAL (APPLIED/EXPLORATORY)
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $37,360 - Friday the 4th of November 2011
Department Of Army
W40M PACIFIC RGNL CNTRG OFC
ANALYTICAL SERVICES>3 GRAMS - RELEASE FY12 FUNDS - $19,175 - Tuesday the 14th of August 2012
Department Of Army
W40M PACIFIC RGNL CNTRG OFC
ANALYTICAL SERVICES>3 GRAMS - INCREASE QUANTITY TO OPTION II AND OPTION III. - $16,514 - Saturday the 1st of December 2012
National Institutes Of Health
NIH, NHLBI, DERA OA OFC ACQUISTIONS
IGF::CL::IGF CLOSELY ASSOCIATED:PERFORM LABORATORY ANALYSIS O FTISSUE AND BLOOD SAMPLES TO COMPLETE PRECLINICAL EXPERIMENTS. - $11,228 - Saturday the 1st of December 2012
National Institutes Of Health
NIH, NHLBI, DERA OA OFC ACQUISTIONS
IGF::CL::IGF CLOSELY ASSOCIATED: THIS SERVICE TO BE PERFORMED IS MICROSPHERE ANALYSIS FOR BLOOD FLOW CALCULATION OF TISSUE AN DREFERENCE BLOOD SAMPLES OF CANINE MYOCARDIAL TISSUE.
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.